A Phase 3b, Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B Who Have Limited Treatment Options
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Expanded access; Therapeutic Use
- Sponsors Gilead Sciences
- 13 Jan 2014 New trial record